A phase IIa, single-center, randomized, observer-blind, placebo- and reference-controlled proof of concept study with intraindividual comparison of treatments to investigate the safety and antipsoriatic efficacy of topical valrubicin formulations in a psoriasis plaque test.
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2011
At a glance
- Drugs Betamethasone valerate; Calcipotriol; Valrubicin
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 21 Jun 2011 New trial record